IBDEI0D2 ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32773,1,3,0)
 ;;=3^Chronic Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,32773,1,4,0)
 ;;=4^R53.82
 ;;^UTILITY(U,$J,358.3,32773,2)
 ;;=^5019519
 ;;^UTILITY(U,$J,358.3,32774,0)
 ;;=R03.0^^99^1350^21
 ;;^UTILITY(U,$J,358.3,32774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32774,1,3,0)
 ;;=3^Elevated BP w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,32774,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,32774,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,32775,0)
 ;;=R00.2^^99^1350^38
 ;;^UTILITY(U,$J,358.3,32775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32775,1,3,0)
 ;;=3^Palpitations
 ;;^UTILITY(U,$J,358.3,32775,1,4,0)
 ;;=4^R00.2
 ;;^UTILITY(U,$J,358.3,32775,2)
 ;;=^5019165
 ;;^UTILITY(U,$J,358.3,32776,0)
 ;;=M33.20^^99^1350^41
 ;;^UTILITY(U,$J,358.3,32776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32776,1,3,0)
 ;;=3^Polymyositis
 ;;^UTILITY(U,$J,358.3,32776,1,4,0)
 ;;=4^M33.20
 ;;^UTILITY(U,$J,358.3,32776,2)
 ;;=^5011770
 ;;^UTILITY(U,$J,358.3,32777,0)
 ;;=R80.9^^99^1350^46
 ;;^UTILITY(U,$J,358.3,32777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32777,1,3,0)
 ;;=3^Proteinuria
 ;;^UTILITY(U,$J,358.3,32777,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,32777,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,32778,0)
 ;;=R76.11^^99^1350^42
 ;;^UTILITY(U,$J,358.3,32778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32778,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,32778,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,32778,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,32779,0)
 ;;=M35.00^^99^1350^50
 ;;^UTILITY(U,$J,358.3,32779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32779,1,3,0)
 ;;=3^Sjogren Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,32779,1,4,0)
 ;;=4^M35.00
 ;;^UTILITY(U,$J,358.3,32779,2)
 ;;=^5011786
 ;;^UTILITY(U,$J,358.3,32780,0)
 ;;=B37.0^^99^1350^56
 ;;^UTILITY(U,$J,358.3,32780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32780,1,3,0)
 ;;=3^Thrush
 ;;^UTILITY(U,$J,358.3,32780,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,32780,2)
 ;;=Thrush^5000612
 ;;^UTILITY(U,$J,358.3,32781,0)
 ;;=R51.9^^99^1350^27
 ;;^UTILITY(U,$J,358.3,32781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32781,1,3,0)
 ;;=3^Headache,Unspecified
 ;;^UTILITY(U,$J,358.3,32781,1,4,0)
 ;;=4^R51.9
 ;;^UTILITY(U,$J,358.3,32781,2)
 ;;=^5159306
 ;;^UTILITY(U,$J,358.3,32782,0)
 ;;=R51.0^^99^1350^26
 ;;^UTILITY(U,$J,358.3,32782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32782,1,3,0)
 ;;=3^Headache w/ Orthostatic Component,NEC
 ;;^UTILITY(U,$J,358.3,32782,1,4,0)
 ;;=4^R51.0
 ;;^UTILITY(U,$J,358.3,32782,2)
 ;;=^5159305
 ;;^UTILITY(U,$J,358.3,32783,0)
 ;;=R05.9^^99^1350^13
 ;;^UTILITY(U,$J,358.3,32783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32783,1,3,0)
 ;;=3^Cough,Unspec
 ;;^UTILITY(U,$J,358.3,32783,1,4,0)
 ;;=4^R05.9
 ;;^UTILITY(U,$J,358.3,32783,2)
 ;;=^5161232
 ;;^UTILITY(U,$J,358.3,32784,0)
 ;;=I83.91^^99^1351^12
 ;;^UTILITY(U,$J,358.3,32784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32784,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,32784,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,32784,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,32785,0)
 ;;=I83.92^^99^1351^11
 ;;^UTILITY(U,$J,358.3,32785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32785,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,32785,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,32785,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,32786,0)
 ;;=I83.93^^99^1351^10
 ;;^UTILITY(U,$J,358.3,32786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32786,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
 ;;^UTILITY(U,$J,358.3,32786,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,32786,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,32787,0)
 ;;=I83.019^^99^1351^9
 ;;^UTILITY(U,$J,358.3,32787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32787,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,32787,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,32787,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,32788,0)
 ;;=I83.029^^99^1351^8
 ;;^UTILITY(U,$J,358.3,32788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32788,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,32788,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,32788,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,32789,0)
 ;;=I71.4^^99^1351^1
 ;;^UTILITY(U,$J,358.3,32789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32789,1,3,0)
 ;;=3^AAA w/o rupture
 ;;^UTILITY(U,$J,358.3,32789,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,32789,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,32790,0)
 ;;=I73.9^^99^1351^3
 ;;^UTILITY(U,$J,358.3,32790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32790,1,3,0)
 ;;=3^PVD, unspec
 ;;^UTILITY(U,$J,358.3,32790,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,32790,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,32791,0)
 ;;=I80.201^^99^1351^4
 ;;^UTILITY(U,$J,358.3,32791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32791,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, right lower extremity
 ;;^UTILITY(U,$J,358.3,32791,1,4,0)
 ;;=4^I80.201
 ;;^UTILITY(U,$J,358.3,32791,2)
 ;;=^5007828
 ;;^UTILITY(U,$J,358.3,32792,0)
 ;;=I80.202^^99^1351^5
 ;;^UTILITY(U,$J,358.3,32792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32792,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, left lower extremities
 ;;^UTILITY(U,$J,358.3,32792,1,4,0)
 ;;=4^I80.202
 ;;^UTILITY(U,$J,358.3,32792,2)
 ;;=^5007829
 ;;^UTILITY(U,$J,358.3,32793,0)
 ;;=I80.203^^99^1351^6
 ;;^UTILITY(U,$J,358.3,32793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32793,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, bilateral lower extremities
 ;;^UTILITY(U,$J,358.3,32793,1,4,0)
 ;;=4^I80.203
 ;;^UTILITY(U,$J,358.3,32793,2)
 ;;=^5007830
 ;;^UTILITY(U,$J,358.3,32794,0)
 ;;=I80.3^^99^1351^7
 ;;^UTILITY(U,$J,358.3,32794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32794,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis of lower extremities, unspec
 ;;^UTILITY(U,$J,358.3,32794,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,32794,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,32795,0)
 ;;=I95.9^^99^1351^2
 ;;^UTILITY(U,$J,358.3,32795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32795,1,3,0)
 ;;=3^Hypotension, unspecified
 ;;^UTILITY(U,$J,358.3,32795,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,32795,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,32796,0)
 ;;=Z51.81^^99^1352^25
 ;;^UTILITY(U,$J,358.3,32796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32796,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,32796,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,32796,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,32797,0)
 ;;=D68.51^^99^1352^1
 ;;^UTILITY(U,$J,358.3,32797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32797,1,3,0)
 ;;=3^Activated Protein C Resistance
 ;;^UTILITY(U,$J,358.3,32797,1,4,0)
 ;;=4^D68.51
 ;;^UTILITY(U,$J,358.3,32797,2)
 ;;=^5002358
 ;;^UTILITY(U,$J,358.3,32798,0)
 ;;=I82.402^^99^1352^2
 ;;^UTILITY(U,$J,358.3,32798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32798,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,32798,1,4,0)
 ;;=4^I82.402
 ;;^UTILITY(U,$J,358.3,32798,2)
 ;;=^5007855
 ;;^UTILITY(U,$J,358.3,32799,0)
 ;;=I82.401^^99^1352^3
 ;;^UTILITY(U,$J,358.3,32799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32799,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,32799,1,4,0)
 ;;=4^I82.401
 ;;^UTILITY(U,$J,358.3,32799,2)
 ;;=^5007854
 ;;^UTILITY(U,$J,358.3,32800,0)
 ;;=I82.890^^99^1352^4
 ;;^UTILITY(U,$J,358.3,32800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32800,1,3,0)
 ;;=3^Acute Embolism/Thrombosis of Specified Veins
 ;;^UTILITY(U,$J,358.3,32800,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,32800,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,32801,0)
 ;;=D68.61^^99^1352^6
 ;;^UTILITY(U,$J,358.3,32801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32801,1,3,0)
 ;;=3^Antiphospholipid Syndrome
 ;;^UTILITY(U,$J,358.3,32801,1,4,0)
 ;;=4^D68.61
 ;;^UTILITY(U,$J,358.3,32801,2)
 ;;=^185421
 ;;^UTILITY(U,$J,358.3,32802,0)
 ;;=I63.50^^99^1352^7
 ;;^UTILITY(U,$J,358.3,32802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32802,1,3,0)
 ;;=3^Cerebral Infarction d/t Occls/Stenos of Cereb Artery
 ;;^UTILITY(U,$J,358.3,32802,1,4,0)
 ;;=4^I63.50
 ;;^UTILITY(U,$J,358.3,32802,2)
 ;;=^5007343
 ;;^UTILITY(U,$J,358.3,32803,0)
 ;;=I82.91^^99^1352^8
 ;;^UTILITY(U,$J,358.3,32803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32803,1,3,0)
 ;;=3^Chronic Embolism/Thrombosis Unspec Vein
 ;;^UTILITY(U,$J,358.3,32803,1,4,0)
 ;;=4^I82.91
 ;;^UTILITY(U,$J,358.3,32803,2)
 ;;=^5007941
 ;;^UTILITY(U,$J,358.3,32804,0)
 ;;=I25.9^^99^1352^10
 ;;^UTILITY(U,$J,358.3,32804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32804,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,32804,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,32804,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,32805,0)
 ;;=D68.9^^99^1352^11
 ;;^UTILITY(U,$J,358.3,32805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32805,1,3,0)
 ;;=3^Coagulation Defect,Unspec
 ;;^UTILITY(U,$J,358.3,32805,1,4,0)
 ;;=4^D68.9
 ;;^UTILITY(U,$J,358.3,32805,2)
 ;;=^5002364
 ;;^UTILITY(U,$J,358.3,32806,0)
 ;;=D68.8^^99^1352^12
 ;;^UTILITY(U,$J,358.3,32806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32806,1,3,0)
 ;;=3^Coagulation Defects,Other Spec
 ;;^UTILITY(U,$J,358.3,32806,1,4,0)
 ;;=4^D68.8
 ;;^UTILITY(U,$J,358.3,32806,2)
 ;;=^5002363
 ;;^UTILITY(U,$J,358.3,32807,0)
 ;;=D68.318^^99^1352^13
 ;;^UTILITY(U,$J,358.3,32807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32807,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrinsic Circ Anticoagulants
 ;;^UTILITY(U,$J,358.3,32807,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,32807,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,32808,0)
 ;;=Z79.01^^99^1352^14
 ;;^UTILITY(U,$J,358.3,32808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32808,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,32808,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,32808,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,32809,0)
 ;;=Z79.02^^99^1352^15
 ;;^UTILITY(U,$J,358.3,32809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32809,1,3,0)
 ;;=3^Long Term (Current) use of Antithrombotics/Antiplatelets
 ;;^UTILITY(U,$J,358.3,32809,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,32809,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,32810,0)
 ;;=D68.62^^99^1352^16
 ;;^UTILITY(U,$J,358.3,32810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32810,1,3,0)
 ;;=3^Lupus Anticoagulant Syndrome
 ;;^UTILITY(U,$J,358.3,32810,1,4,0)
 ;;=4^D68.62
 ;;^UTILITY(U,$J,358.3,32810,2)
 ;;=^5002361
 ;;^UTILITY(U,$J,358.3,32811,0)
 ;;=I73.9^^99^1352^17
 ;;^UTILITY(U,$J,358.3,32811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32811,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,32811,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,32811,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,32812,0)
 ;;=Z86.79^^99^1352^18
 ;;^UTILITY(U,$J,358.3,32812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32812,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,32812,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,32812,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,32813,0)
 ;;=Z86.711^^99^1352^19
 ;;^UTILITY(U,$J,358.3,32813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32813,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,32813,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,32813,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,32814,0)
 ;;=Z86.718^^99^1352^20
 ;;^UTILITY(U,$J,358.3,32814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32814,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,32814,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,32814,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,32815,0)
 ;;=Z95.2^^99^1352^21
 ;;^UTILITY(U,$J,358.3,32815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32815,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,32815,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,32815,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,32816,0)
 ;;=D68.59^^99^1352^22
 ;;^UTILITY(U,$J,358.3,32816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32816,1,3,0)
 ;;=3^Primary Thrombophilia
 ;;^UTILITY(U,$J,358.3,32816,1,4,0)
 ;;=4^D68.59
 ;;^UTILITY(U,$J,358.3,32816,2)
 ;;=^5002360
 ;;^UTILITY(U,$J,358.3,32817,0)
 ;;=I26.99^^99^1352^23
 ;;^UTILITY(U,$J,358.3,32817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32817,1,3,0)
 ;;=3^Pulmonary Embolism w/o Acute Cor Pulmonale
 ;;^UTILITY(U,$J,358.3,32817,1,4,0)
 ;;=4^I26.99
 ;;^UTILITY(U,$J,358.3,32817,2)
 ;;=^5007150
 ;;^UTILITY(U,$J,358.3,32818,0)
 ;;=I42.5^^99^1352^24
 ;;^UTILITY(U,$J,358.3,32818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32818,1,3,0)
 ;;=3^Restrictive Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,32818,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,32818,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,32819,0)
 ;;=G45.9^^99^1352^26
 ;;^UTILITY(U,$J,358.3,32819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32819,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,32819,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,32819,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,32820,0)
 ;;=I82.891^^99^1352^9
 ;;^UTILITY(U,$J,358.3,32820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32820,1,3,0)
 ;;=3^Chronic Embolism/Thrombosis,Specified Veins
 ;;^UTILITY(U,$J,358.3,32820,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,32820,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,32821,0)
 ;;=I82.90^^99^1352^5
 ;;^UTILITY(U,$J,358.3,32821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32821,1,3,0)
 ;;=3^Acute Embolism/Thrombosis,Unspec Vein
 ;;^UTILITY(U,$J,358.3,32821,1,4,0)
 ;;=4^I82.90
 ;;^UTILITY(U,$J,358.3,32821,2)
 ;;=^5007940
 ;;^UTILITY(U,$J,358.3,32822,0)
 ;;=R45.851^^99^1353^3
 ;;^UTILITY(U,$J,358.3,32822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32822,1,3,0)
 ;;=3^Suicidal Ideations
 ;;^UTILITY(U,$J,358.3,32822,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,32822,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,32823,0)
 ;;=T14.91XA^^99^1353^4
 ;;^UTILITY(U,$J,358.3,32823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32823,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,32823,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,32823,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,32824,0)
 ;;=T14.91XD^^99^1353^6
 ;;^UTILITY(U,$J,358.3,32824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32824,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,32824,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,32824,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,32825,0)
 ;;=T14.91XS^^99^1353^5
 ;;^UTILITY(U,$J,358.3,32825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32825,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,32825,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,32825,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,32826,0)
 ;;=Z91.51^^99^1353^2
 ;;^UTILITY(U,$J,358.3,32826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32826,1,3,0)
 ;;=3^Personal Hx of Suicidal Behavior
 ;;^UTILITY(U,$J,358.3,32826,1,4,0)
 ;;=4^Z91.51
 ;;^UTILITY(U,$J,358.3,32826,2)
 ;;=^5161317
 ;;^UTILITY(U,$J,358.3,32827,0)
 ;;=Z91.52^^99^1353^1
 ;;^UTILITY(U,$J,358.3,32827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32827,1,3,0)
 ;;=3^Personal Hx of Non-Suicidal Self-Harm
 ;;^UTILITY(U,$J,358.3,32827,1,4,0)
 ;;=4^Z91.52
 ;;^UTILITY(U,$J,358.3,32827,2)
 ;;=^5161318
 ;;^UTILITY(U,$J,358.3,32828,0)
 ;;=J30.1^^99^1354^5
 ;;^UTILITY(U,$J,358.3,32828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32828,1,3,0)
 ;;=3^Allergic Rhinitis,Pollen
 ;;^UTILITY(U,$J,358.3,32828,1,4,0)
 ;;=4^J30.1
 ;;^UTILITY(U,$J,358.3,32828,2)
 ;;=^269906
 ;;^UTILITY(U,$J,358.3,32829,0)
 ;;=J30.2^^99^1354^3
 ;;^UTILITY(U,$J,358.3,32829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32829,1,3,0)
 ;;=3^Allergic Rhinitis,Oth Seasonal
 ;;^UTILITY(U,$J,358.3,32829,1,4,0)
 ;;=4^J30.2
 ;;^UTILITY(U,$J,358.3,32829,2)
 ;;=^5008202
 ;;^UTILITY(U,$J,358.3,32830,0)
 ;;=J30.81^^99^1354^1
 ;;^UTILITY(U,$J,358.3,32830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32830,1,3,0)
 ;;=3^Allergic Rhinitis,Danders
 ;;^UTILITY(U,$J,358.3,32830,1,4,0)
 ;;=4^J30.81
 ;;^UTILITY(U,$J,358.3,32830,2)
 ;;=^5008203
 ;;^UTILITY(U,$J,358.3,32831,0)
 ;;=J30.89^^99^1354^4
 ;;^UTILITY(U,$J,358.3,32831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32831,1,3,0)
 ;;=3^Allergic Rhinitis,Other
 ;;^UTILITY(U,$J,358.3,32831,1,4,0)
 ;;=4^J30.89
 ;;^UTILITY(U,$J,358.3,32831,2)
 ;;=^5008204
 ;;^UTILITY(U,$J,358.3,32832,0)
 ;;=J30.5^^99^1354^2
 ;;^UTILITY(U,$J,358.3,32832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32832,1,3,0)
 ;;=3^Allergic Rhinitis,Food
 ;;^UTILITY(U,$J,358.3,32832,1,4,0)
 ;;=4^J30.5
 ;;^UTILITY(U,$J,358.3,32832,2)
 ;;=^321989
 ;;^UTILITY(U,$J,358.3,32833,0)
 ;;=J30.9^^99^1354^6
 ;;^UTILITY(U,$J,358.3,32833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32833,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,32833,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,32833,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,32834,0)
 ;;=T78.2XXA^^99^1354^40
 ;;^UTILITY(U,$J,358.3,32834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32834,1,3,0)
 ;;=3^Anaphylaxis,Unspec,1st Encntr
 ;;^UTILITY(U,$J,358.3,32834,1,4,0)
 ;;=4^T78.2XXA
 ;;^UTILITY(U,$J,358.3,32834,2)
 ;;=^5054278
 ;;^UTILITY(U,$J,358.3,32835,0)
 ;;=T78.2XXD^^99^1354^42
 ;;^UTILITY(U,$J,358.3,32835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32835,1,3,0)
 ;;=3^Anaphylaxis,Unspec,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,32835,1,4,0)
 ;;=4^T78.2XXD
 ;;^UTILITY(U,$J,358.3,32835,2)
 ;;=^5054279
 ;;^UTILITY(U,$J,358.3,32836,0)
 ;;=T78.2XXS^^99^1354^41
 ;;^UTILITY(U,$J,358.3,32836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32836,1,3,0)
 ;;=3^Anaphylaxis,Unspec,Sequela
 ;;^UTILITY(U,$J,358.3,32836,1,4,0)
 ;;=4^T78.2XXS
 ;;^UTILITY(U,$J,358.3,32836,2)
 ;;=^5054280
 ;;^UTILITY(U,$J,358.3,32837,0)
 ;;=T78.00XA^^99^1354^37
 ;;^UTILITY(U,$J,358.3,32837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32837,1,3,0)
 ;;=3^Anaphylactic Reaction,Unspec Food,1st Encntr
 ;;^UTILITY(U,$J,358.3,32837,1,4,0)
 ;;=4^T78.00XA
 ;;^UTILITY(U,$J,358.3,32837,2)
 ;;=^5054245
 ;;^UTILITY(U,$J,358.3,32838,0)
 ;;=T78.00XD^^99^1354^39
 ;;^UTILITY(U,$J,358.3,32838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32838,1,3,0)
 ;;=3^Anaphylactic Reaction,Unspec Food,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,32838,1,4,0)
 ;;=4^T78.00XD
 ;;^UTILITY(U,$J,358.3,32838,2)
 ;;=^5054246
 ;;^UTILITY(U,$J,358.3,32839,0)
 ;;=T78.00XS^^99^1354^38
 ;;^UTILITY(U,$J,358.3,32839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32839,1,3,0)
 ;;=3^Anaphylactic Reaction,Unspec Food,Sequela
 ;;^UTILITY(U,$J,358.3,32839,1,4,0)
 ;;=4^T78.00XS
 ;;^UTILITY(U,$J,358.3,32839,2)
 ;;=^5054247
 ;;^UTILITY(U,$J,358.3,32840,0)
 ;;=T78.01XA^^99^1354^31
 ;;^UTILITY(U,$J,358.3,32840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32840,1,3,0)
 ;;=3^Anaphylactic Reaction,Peanuts,1st Encntr
 ;;^UTILITY(U,$J,358.3,32840,1,4,0)
 ;;=4^T78.01XA
 ;;^UTILITY(U,$J,358.3,32840,2)
 ;;=^5054248
